These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3089078)

  • 1. [Bilateral prosthesis of the knee in a hemophilia A patient with an inhibitor].
    Lauroua P; Barbier F; Dieu P; Dumora D; Moulinier J
    Ann Fr Anesth Reanim; 1986; 5(2):154-6. PubMed ID: 3089078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of FEIBA (factor eight inhibitor bypassing activity) in cataract extraction in hemophilia A patient with inhibitor.
    Tourbaf KD; Dunlap BE; Ambrus JL; Rodman DJ; Atwal AJ
    J Med; 1982; 13(5-6):399-410. PubMed ID: 6820380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of an activated factor IX complex (Autoplex) in the management of haemarthroses in haemophiliacs with antibodies to factor VIII.
    Aronstam A; McLellan DS; Mbatha PS; Wassef M
    Clin Lab Haematol; 1982; 4(3):231-8. PubMed ID: 6816500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical effects of FEIBA on hemophilia patients with inhibitors to factor VIII or IX].
    Iizuka A; Kuwashima M; Nagao T
    Nihon Ketsueki Gakkai Zasshi; 1982 Sep; 45(5):987-92. PubMed ID: 6818811
    [No Abstract]   [Full Text] [Related]  

  • 5. Laboratory evidence of DIC under FEIBA treatment of a hemophilic patient with intracranial bleeding and high titre factor VIII inhibitor.
    Fukui H; Fujimura Y; Takahashi Y; Mikami S; Yoshioka A
    Thromb Res; 1981 Apr 1-15; 22(1-2):177-84. PubMed ID: 6794176
    [No Abstract]   [Full Text] [Related]  

  • 6. [Inhibitors and "bypass" therapy in hemophilia].
    Fukutake K; Fukutake K
    Nihon Rinsho; 1981; 39(12):3688-99. PubMed ID: 6803034
    [No Abstract]   [Full Text] [Related]  

  • 7. [Severe hemorrhagic syndrome in a high responder patient with hemophilia A. Value of porcine factor VIII].
    Boullet M; Goudemand J; Smith P; Willot I; Ballestrazzi V
    Ann Fr Anesth Reanim; 1989; 8(3):280-3. PubMed ID: 2506779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Massive factor-VIII infusion in Haemophiliac with factor-VIII inhibitor, high responder. 1977.
    Brackmann HH; Gormsen J
    Haemophilia; 2010 May; 16(102):2-3. PubMed ID: 20536980
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of low-dose 'factor VIII inhibitor bypassing activity (FEIBA)' in resistant haemophilia.
    Zwahlen H; Beck EA
    Acta Haematol; 1980; 64(1):12-7. PubMed ID: 6774572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B.
    Nilsson IM; Berntorp E; Löfqvist T; Pettersson H
    J Intern Med; 1992 Jul; 232(1):25-32. PubMed ID: 1640190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The problem of factor VIII inhibitors in patients with congenital coagulopathies].
    Klare M
    Z Gesamte Inn Med; 1983 Jan; 38(2):47-50. PubMed ID: 6407220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Articular and muscular hemorrhages in hemophilia A with anti-factor VIII antibodies. Treatment with selected batches of PPSB (factor IX concentrate)].
    Verroust F; Moussard C; Allain JP
    Presse Med; 1985 May; 14(19):1073-6. PubMed ID: 3158962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of immune responses following 102 infusions of autoplex in 18 hemophilic patients with antibody to factor VIII.
    Laurian Y; Girma JP; Lambert T; Meyer D; Larrieu MJ
    Blood; 1984 Feb; 63(2):457-62. PubMed ID: 6419798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hemophilia complicated by inhibitors.
    Scand J Haematol Suppl; 1980; 35():135-64. PubMed ID: 6770458
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Life-threatening sublingual hematoma in a severely hemophilic patient with factor VIII inhibitor.
    Takeuchi M; Shikimori M; Kaneda T
    J Oral Maxillofac Surg; 1986 May; 44(5):401-3. PubMed ID: 3084733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.
    Hay CR; Brown S; Collins PW; Keeling DM; Liesner R
    Br J Haematol; 2006 Jun; 133(6):591-605. PubMed ID: 16704433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of joint damage in hemophilic children with early prophylaxis].
    Kreuz W; Escuriola Ettingshausen C; Funk M; Pons S; Schmidt H; Kornhuber B
    Orthopade; 1999 Apr; 28(4):341-6. PubMed ID: 10335528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
    Mahasandana C; Patharathienskul D; Suvatte V
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemophilic arthropathy. Current concepts of pathogenesis and management.
    Arnold WD; Hilgartner MW
    J Bone Joint Surg Am; 1977 Apr; 59(3):287-305. PubMed ID: 849938
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.